"Skin Biopsy Test for Parkinson's Diagnosis Confirmed at AAN 2024"
The Syn-One test, which uses a skin biopsy to detect atypical clumps of the protein alpha-synuclein, shows promise in confirming Parkinson's disease diagnosis and guiding treatment decisions. Data presented at the AAN 2024 Annual Meeting revealed that the test led to changes in diagnosis and treatment for a significant number of patients evaluated for Parkinson's. The test's potential impact on clinical decision-making and its ability to aid in confirming related medical conditions were highlighted, emphasizing the need for earlier and accurate diagnosis of neurodegenerative disorders.
